Related Topics News -

     
 < Previous page   Detail   |   Print 
     
《大行》美銀證券料藥明康德繼續搶佔市場份額 升目標價至123元
2025-08-05T  
方達控股首席財務官變動
2025-07-14T  
《大行》匯豐研究:創新藥臨床試驗需求正轉向中國 上調泰格醫藥目標價至41.8元
2025-06-20T  
特朗普:下周宣布有關藥品成本消息
2025-05-06T  
方達控股首季經調整純利倒退27%至160萬美元
2025-04-28T  
美國藥典委員會警告潛在關稅或打擊仿製藥公司
2025-04-24T  
《業績》方達控股全年純利79.1萬美元
2025-03-27T  
方達控股行政總裁變更
2025-01-06T  
《業績》方達控股首三季純利按年大跌98%
2024-10-29T  
 < Previous page 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.